POTASSIUM-BINDING AGENTS FOR TREATING HYPERTENSION AND HYPERKALEMIA
    6.
    发明公开
    POTASSIUM-BINDING AGENTS FOR TREATING HYPERTENSION AND HYPERKALEMIA 审中-公开
    钾结合剂高血压和高血钾症的治疗

    公开(公告)号:EP2916851A2

    公开(公告)日:2015-09-16

    申请号:EP13779499.6

    申请日:2013-10-08

    申请人: Relypsa, Inc.

    摘要: The present invention generally relates to methods of treating hypertension (HTN) in patients in need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). The invention also relates to methods of treating hyperkalemia in a patient in need thereof, wherein the patient suffers from CKD, T2DM or HTN and are optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The invention also relates to methods of treating kidney disease in a patient in need thereof, wherein the patient is optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The methods can comprise administering an effective amount of a potassium-binding agent to the patient to lower the patient's blood pressure and/or increase or stabilize the patient's kidney function.